Global Cell Therapy and Gene Therapy CDMO Market Research Report 2024, Forecast to 2032

October 2024 | 144 pages | ID: G63907E4598DEN
Bosson Research

Abstracts

Report Overview

Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.

The global Cell Therapy and Gene Therapy CDMO market size was estimated at USD 3120 million in 2023 and is projected to reach USD 16098.51 million by 2032, exhibiting a CAGR of 20.00% during the forecast period.

North America Cell Therapy and Gene Therapy CDMO market size was estimated at USD 1115.61 million in 2023, at a CAGR of 17.14% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Cell Therapy and Gene Therapy CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell Therapy and Gene Therapy CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell Therapy and Gene Therapy CDMO market in any manner.

Global Cell Therapy and Gene Therapy CDMO Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Lonza Pharmaceuticals

Thermo Fisher

catalent

Jubilant LifeSciences

Boehringer Ingelheim

Oxford BioMedica

Charles River

WuXi AppTec

He Yuan Biology

GenScript Biotech

Kanglong Chemical

Porton shares

Sano Biologics

Yunzhou Biology

Market Segmentation (by Type)

Cell Therapy

Gene Therapy

Market Segmentation (by Application)

Clinical Stage Projects

Commercialization Stage Projects

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cell Therapy and Gene Therapy CDMO Market
• Overview of the regional outlook of the Cell Therapy and Gene Therapy CDMO Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy and Gene Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Cell Therapy and Gene Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Cell Therapy and Gene Therapy CDMO
1.2 Key Market Segments
  1.2.1 Cell Therapy and Gene Therapy CDMO Segment by Type
  1.2.2 Cell Therapy and Gene Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CELL THERAPY AND GENE THERAPY CDMO MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) Estimates and Forecasts (2019-2032)
  2.1.2 Global Cell Therapy and Gene Therapy CDMO Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CELL THERAPY AND GENE THERAPY CDMO MARKET COMPETITIVE LANDSCAPE

3.1 Global Cell Therapy and Gene Therapy CDMO Sales by Manufacturers (2019-2024)
3.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell Therapy and Gene Therapy CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell Therapy and Gene Therapy CDMO Sales Sites, Area Served, Product Type
3.6 Cell Therapy and Gene Therapy CDMO Market Competitive Situation and Trends
  3.6.1 Cell Therapy and Gene Therapy CDMO Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Cell Therapy and Gene Therapy CDMO Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 CELL THERAPY AND GENE THERAPY CDMO INDUSTRY CHAIN ANALYSIS

4.1 Cell Therapy and Gene Therapy CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY AND GENE THERAPY CDMO MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 CELL THERAPY AND GENE THERAPY CDMO MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Type (2019-2024)
6.3 Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Cell Therapy and Gene Therapy CDMO Price by Type (2019-2024)

7 CELL THERAPY AND GENE THERAPY CDMO MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy and Gene Therapy CDMO Market Sales by Application (2019-2024)
7.3 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)

8 CELL THERAPY AND GENE THERAPY CDMO MARKET CONSUMPTION BY REGION

8.1 Global Cell Therapy and Gene Therapy CDMO Sales by Region
  8.1.1 Global Cell Therapy and Gene Therapy CDMO Sales by Region
  8.1.2 Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region
8.2 North America
  8.2.1 North America Cell Therapy and Gene Therapy CDMO Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Cell Therapy and Gene Therapy CDMO Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Cell Therapy and Gene Therapy CDMO Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Cell Therapy and Gene Therapy CDMO Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 CELL THERAPY AND GENE THERAPY CDMO MARKET PRODUCTION BY REGION

9.1 Global Production of Cell Therapy and Gene Therapy CDMO by Region (2019-2024)
9.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2019-2024)
9.3 Global Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Cell Therapy and Gene Therapy CDMO Production
  9.4.1 North America Cell Therapy and Gene Therapy CDMO Production Growth Rate (2019-2024)
  9.4.2 North America Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Cell Therapy and Gene Therapy CDMO Production
  9.5.1 Europe Cell Therapy and Gene Therapy CDMO Production Growth Rate (2019-2024)
  9.5.2 Europe Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Cell Therapy and Gene Therapy CDMO Production (2019-2024)
  9.6.1 Japan Cell Therapy and Gene Therapy CDMO Production Growth Rate (2019-2024)
  9.6.2 Japan Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Cell Therapy and Gene Therapy CDMO Production (2019-2024)
  9.7.1 China Cell Therapy and Gene Therapy CDMO Production Growth Rate (2019-2024)
  9.7.2 China Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2019-2024)

10 KEY COMPANIES PROFILE

10.1 Lonza Pharmaceuticals
  10.1.1 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Basic Information
  10.1.2 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Overview
  10.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.1.4 Lonza Pharmaceuticals Business Overview
  10.1.5 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO SWOT Analysis
  10.1.6 Lonza Pharmaceuticals Recent Developments
10.2 Thermo Fisher
  10.2.1 Thermo Fisher Cell Therapy and Gene Therapy CDMO Basic Information
  10.2.2 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Overview
  10.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.2.4 Thermo Fisher Business Overview
  10.2.5 Thermo Fisher Cell Therapy and Gene Therapy CDMO SWOT Analysis
  10.2.6 Thermo Fisher Recent Developments
10.3 catalent
  10.3.1 catalent Cell Therapy and Gene Therapy CDMO Basic Information
  10.3.2 catalent Cell Therapy and Gene Therapy CDMO Product Overview
  10.3.3 catalent Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.3.4 catalent Cell Therapy and Gene Therapy CDMO SWOT Analysis
  10.3.5 catalent Business Overview
  10.3.6 catalent Recent Developments
10.4 Jubilant LifeSciences
  10.4.1 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Basic Information
  10.4.2 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Overview
  10.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.4.4 Jubilant LifeSciences Business Overview
  10.4.5 Jubilant LifeSciences Recent Developments
10.5 Boehringer Ingelheim
  10.5.1 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Basic Information
  10.5.2 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Overview
  10.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.5.4 Boehringer Ingelheim Business Overview
  10.5.5 Boehringer Ingelheim Recent Developments
10.6 Oxford BioMedica
  10.6.1 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Basic Information
  10.6.2 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Overview
  10.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.6.4 Oxford BioMedica Business Overview
  10.6.5 Oxford BioMedica Recent Developments
10.7 Charles River
  10.7.1 Charles River Cell Therapy and Gene Therapy CDMO Basic Information
  10.7.2 Charles River Cell Therapy and Gene Therapy CDMO Product Overview
  10.7.3 Charles River Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.7.4 Charles River Business Overview
  10.7.5 Charles River Recent Developments
10.8 WuXi AppTec
  10.8.1 WuXi AppTec Cell Therapy and Gene Therapy CDMO Basic Information
  10.8.2 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Overview
  10.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.8.4 WuXi AppTec Business Overview
  10.8.5 WuXi AppTec Recent Developments
10.9 He Yuan Biology
  10.9.1 He Yuan Biology Cell Therapy and Gene Therapy CDMO Basic Information
  10.9.2 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Overview
  10.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.9.4 He Yuan Biology Business Overview
  10.9.5 He Yuan Biology Recent Developments
10.10 GenScript Biotech
  10.10.1 GenScript Biotech Cell Therapy and Gene Therapy CDMO Basic Information
  10.10.2 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Overview
  10.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.10.4 GenScript Biotech Business Overview
  10.10.5 GenScript Biotech Recent Developments
10.11 Kanglong Chemical
  10.11.1 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Basic Information
  10.11.2 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Overview
  10.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.11.4 Kanglong Chemical Business Overview
  10.11.5 Kanglong Chemical Recent Developments
10.12 Porton shares
  10.12.1 Porton shares Cell Therapy and Gene Therapy CDMO Basic Information
  10.12.2 Porton shares Cell Therapy and Gene Therapy CDMO Product Overview
  10.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.12.4 Porton shares Business Overview
  10.12.5 Porton shares Recent Developments
10.13 Sano Biologics
  10.13.1 Sano Biologics Cell Therapy and Gene Therapy CDMO Basic Information
  10.13.2 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Overview
  10.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.13.4 Sano Biologics Business Overview
  10.13.5 Sano Biologics Recent Developments
10.14 Yunzhou Biology
  10.14.1 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Basic Information
  10.14.2 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Overview
  10.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Market Performance
  10.14.4 Yunzhou Biology Business Overview
  10.14.5 Yunzhou Biology Recent Developments

11 CELL THERAPY AND GENE THERAPY CDMO MARKET FORECAST BY REGION

11.1 Global Cell Therapy and Gene Therapy CDMO Market Size Forecast
11.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country
  11.2.3 Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region
  11.2.4 South America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Consumption of Cell Therapy and Gene Therapy CDMO by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)

12.1 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Type (2025-2032)
  12.1.1 Global Forecasted Sales of Cell Therapy and Gene Therapy CDMO by Type (2025-2032)
  12.1.2 Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2025-2032)
  12.1.3 Global Forecasted Price of Cell Therapy and Gene Therapy CDMO by Type (2025-2032)
12.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Application (2025-2032)
  12.2.1 Global Cell Therapy and Gene Therapy CDMO Sales (K Units) Forecast by Application
  12.2.2 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) Forecast by Application (2025-2032)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell Therapy and Gene Therapy CDMO Market Size Comparison by Region (M USD)
Table 5. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell Therapy and Gene Therapy CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2022)
Table 10. Global Market Cell Therapy and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell Therapy and Gene Therapy CDMO Sales Sites and Area Served
Table 12. Manufacturers Cell Therapy and Gene Therapy CDMO Product Type
Table 13. Global Cell Therapy and Gene Therapy CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell Therapy and Gene Therapy CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell Therapy and Gene Therapy CDMO Market Challenges
Table 22. Global Cell Therapy and Gene Therapy CDMO Sales by Type (K Units)
Table 23. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (M USD)
Table 24. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell Therapy and Gene Therapy CDMO Market Size Share by Type (2019-2024)
Table 28. Global Cell Therapy and Gene Therapy CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Application
Table 30. Global Cell Therapy and Gene Therapy CDMO Market Size by Application
Table 31. Global Cell Therapy and Gene Therapy CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Cell Therapy and Gene Therapy CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell Therapy and Gene Therapy CDMO Market Share by Application (2019-2024)
Table 35. Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell Therapy and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Cell Therapy and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell Therapy and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell Therapy and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Global Cell Therapy and Gene Therapy CDMO Production (K Units) by Region (2019-2024)
Table 44. Global Cell Therapy and Gene Therapy CDMO Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2019-2024)
Table 46. Global Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Basic Information
Table 52. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Overview
Table 53. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Lonza Pharmaceuticals Business Overview
Table 55. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO SWOT Analysis
Table 56. Lonza Pharmaceuticals Recent Developments
Table 57. Thermo Fisher Cell Therapy and Gene Therapy CDMO Basic Information
Table 58. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Overview
Table 59. Thermo Fisher Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Thermo Fisher Business Overview
Table 61. Thermo Fisher Cell Therapy and Gene Therapy CDMO SWOT Analysis
Table 62. Thermo Fisher Recent Developments
Table 63. catalent Cell Therapy and Gene Therapy CDMO Basic Information
Table 64. catalent Cell Therapy and Gene Therapy CDMO Product Overview
Table 65. catalent Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. catalent Cell Therapy and Gene Therapy CDMO SWOT Analysis
Table 67. catalent Business Overview
Table 68. catalent Recent Developments
Table 69. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Basic Information
Table 70. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Overview
Table 71. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Jubilant LifeSciences Business Overview
Table 73. Jubilant LifeSciences Recent Developments
Table 74. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Basic Information
Table 75. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Overview
Table 76. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Basic Information
Table 80. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Overview
Table 81. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Oxford BioMedica Business Overview
Table 83. Oxford BioMedica Recent Developments
Table 84. Charles River Cell Therapy and Gene Therapy CDMO Basic Information
Table 85. Charles River Cell Therapy and Gene Therapy CDMO Product Overview
Table 86. Charles River Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Charles River Business Overview
Table 88. Charles River Recent Developments
Table 89. WuXi AppTec Cell Therapy and Gene Therapy CDMO Basic Information
Table 90. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Overview
Table 91. WuXi AppTec Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. WuXi AppTec Business Overview
Table 93. WuXi AppTec Recent Developments
Table 94. He Yuan Biology Cell Therapy and Gene Therapy CDMO Basic Information
Table 95. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Overview
Table 96. He Yuan Biology Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. He Yuan Biology Business Overview
Table 98. He Yuan Biology Recent Developments
Table 99. GenScript Biotech Cell Therapy and Gene Therapy CDMO Basic Information
Table 100. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Overview
Table 101. GenScript Biotech Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. GenScript Biotech Business Overview
Table 103. GenScript Biotech Recent Developments
Table 104. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Basic Information
Table 105. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Overview
Table 106. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Kanglong Chemical Business Overview
Table 108. Kanglong Chemical Recent Developments
Table 109. Porton shares Cell Therapy and Gene Therapy CDMO Basic Information
Table 110. Porton shares Cell Therapy and Gene Therapy CDMO Product Overview
Table 111. Porton shares Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Porton shares Business Overview
Table 113. Porton shares Recent Developments
Table 114. Sano Biologics Cell Therapy and Gene Therapy CDMO Basic Information
Table 115. Sano Biologics Cell Therapy and Gene Therapy CDMO Product Overview
Table 116. Sano Biologics Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Sano Biologics Business Overview
Table 118. Sano Biologics Recent Developments
Table 119. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Basic Information
Table 120. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Overview
Table 121. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Yunzhou Biology Business Overview
Table 123. Yunzhou Biology Recent Developments
Table 124. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Region (2025-2032) & (K Units)
Table 125. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2025-2032) & (K Units)
Table 127. North America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2025-2032) & (K Units)
Table 129. Europe Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales Forecast by Region (2025-2032) & (K Units)
Table 131. Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2025-2032) & (K Units)
Table 133. South America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Cell Therapy and Gene Therapy CDMO Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Type (2025-2032) & (K Units)
Table 137. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Cell Therapy and Gene Therapy CDMO Price Forecast by Type (2025-2032) & (USD/Unit)
Table 139. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) Forecast by Application (2025-2032)
Table 140. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Application (2025-2032) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Cell Therapy and Gene Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD), 2019-2032
Figure 5. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) (2019-2032)
Figure 6. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell Therapy and Gene Therapy CDMO Market Size by Country (M USD)
Figure 11. Cell Therapy and Gene Therapy CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Manufacturers in 2023
Figure 13. Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell Therapy and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell Therapy and Gene Therapy CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell Therapy and Gene Therapy CDMO Market Share by Type
Figure 18. Sales Market Share of Cell Therapy and Gene Therapy CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Cell Therapy and Gene Therapy CDMO by Type in 2023
Figure 20. Market Size Share of Cell Therapy and Gene Therapy CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Cell Therapy and Gene Therapy CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell Therapy and Gene Therapy CDMO Market Share by Application
Figure 24. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application in 2023
Figure 26. Global Cell Therapy and Gene Therapy CDMO Market Share by Application (2019-2024)
Figure 27. Global Cell Therapy and Gene Therapy CDMO Market Share by Application in 2023
Figure 28. Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell Therapy and Gene Therapy CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell Therapy and Gene Therapy CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 37. Germany Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales Market Share by Region in 2023
Figure 44. China Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 50. South America Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell Therapy and Gene Therapy CDMO Production Market Share by Region (2019-2024)
Figure 62. North America Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2019-2024)
Figure 65. China Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Cell Therapy and Gene Therapy CDMO Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Type (2025-2032)
Figure 70. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Application (2025-2032)
Figure 71. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Application (2025-2032)